Biliverdin inhibits Toll-like receptor-4 (TLR4) expression through nitric oxide-dependent nuclear translocation of biliverdin reductase
- 31 October 2011
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 108 (46), 18849-18854
- https://doi.org/10.1073/pnas.1108571108
Abstract
The cellular response to an inflammatory stressor requires a proinflammatory cellular activation followed by a controlled resolution of the response to restore homeostasis. We hypothesized that biliverdin reductase (BVR) by binding biliverdin (BV) quells the cellular response to endotoxin-induced inflammation through phosphorylation of endothelial nitric oxide synthase (eNOS). The generated NO, in turn, nitrosylates BVR, leading to nuclear translocation where BVR binds to the Toll-like receptor-4 (TLR4) promoter at the Ap-1 sites to block transcription. We show in macrophages that BV-induced eNOS phosphorylation (Ser-1177) and NO production are mediated in part by Ca(2+)/calmodulin-dependent kinase kinase. Furthermore, we show that BVR is S-nitrosylated on one of three cysteines and that this posttranslational modification is required for BVR-mediated signaling. BV-induced nuclear translocation of BVR and inhibition of TLR4 expression is lost in macrophages derived from Enos(-/-) mice. In vivo in mice, BV provides protection from acute liver damage and is dependent on the availability of NO. Collectively, we elucidate a mechanism for BVR in regulating the inflammatory response to endotoxin that requires eNOS-derived NO and TLR4 signaling in macrophages.This publication has 40 references indexed in Scilit:
- Cell Surface Biliverdin Reductase Mediates Biliverdin-induced Anti-inflammatory Effects via Phosphatidylinositol 3-Kinase and AktOnline Journal of Public Health Informatics, 2009
- Bilirubin and glutathione have complementary antioxidant and cytoprotective rolesProceedings of the National Academy of Sciences of the United States of America, 2009
- Multiple Cellular Mechanisms Related to Cyclin A1 in Prostate Cancer Invasion and MetastasisJNCI Journal of the National Cancer Institute, 2008
- Human biliverdin reductase is an ERK activator; hBVR is an ERK nuclear transporter and is required for MAPK signalingProceedings of the National Academy of Sciences of the United States of America, 2008
- Regulation of MyD88-Dependent Signaling Events by S Nitrosylation Retards Toll-Like Receptor Signal Transduction and Initiation of Acute-Phase Immune ResponsesMolecular and Cellular Biology, 2008
- Hypoxia-inducible factor 1α stabilization by carbon monoxide results in cytoprotective preconditioningProceedings of the National Academy of Sciences of the United States of America, 2007
- S-Nitrosylation: NO-Related Redox Signaling to Protect Against Oxidative StressAntioxidants and Redox Signaling, 2006
- TLR4 expression in mouse embryonic stem cells and in stem cell-derived vascular cells is regulated by epigenetic modificationsBiochemical and Biophysical Research Communications, 2006
- Heme Oxygenase-1 and Transplantation ToleranceHuman Immunology, 2006
- Biliverdin administration protects against endotoxin-induced acute lung injury in ratsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2005